POSC134 Cost-Effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.538
https://www.valueinhealthjournal.com/article/S1098-3015(21)02333-0/fulltext
Section Title :
Section Order :
10075
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02333-0&doi=10.1016/j.jval.2021.11.538